ATF4 and ovarian cancer: In addition, the overall survival of ovarian cancer patients with high levels of CCDC106 and ATF4 was significantly lower than patients with low levels of CCDC106 (p = 0.0088) and ATF4 (p = 0.0045) (Figure 10d, e).